id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-H-0065-0035,FDA,FDA-2002-H-0065,"HF-3, Administrative Law Judge",Rule,SET-Settlement Agreement,2003-11-07T05:00:00Z,2003,11,,,2008-04-12T01:19:18Z,,0,0,090000648048c668
FDA-2002-H-0065-0034,FDA,FDA-2002-H-0065,"HFZ-215, GCF-1, and Patton Boggs. LLP",Rule,SET-Settlement Agreement,2003-11-06T05:00:00Z,2003,11,,,2008-04-12T01:19:19Z,,0,0,090000648048c667
FDA-1978-N-0007-0003,FDA,FDA-1978-N-0007,"Notice of Confirmation of Effective Date re Skin Protectant Drug Products for Over-the-Counter Human Use, Astringent Drug Products; Final Monograph, Direct Final Rule; and Confirmation of Effective Date",Rule,Notice of Confirmation of Effective Date,2003-10-15T04:00:00Z,2003,10,,,2018-05-03T16:20:06Z,,0,0,09000064805585a4
FDA-2002-E-0160-0002,FDA,FDA-2002-E-0160,Notice of Final Determination,Rule,Certificate Extending Patent Term,2003-10-06T04:00:00Z,2003,10,,,2025-09-30T00:14:18Z,,0,0,090000648049406c
FDA-2002-P-0046-0002,FDA,FDA-2002-P-0046,Food Labeling: Health Claims; D-tagatose and Dental Caries; Final Rule,Rule,Final Rule,2003-07-08T04:00:00Z,2003,7,2003-07-01T04:00:00Z,,2015-12-02T21:01:52Z,,0,0,090000648048b816
FDA-1978-N-0027-0048,FDA,FDA-1978-N-0027,Tab N: Letter of Acknowledgment from FDA to Revlon Health Care Group Re: Skin Protectant Drug Products for Over the Counter Human Use; Final Monograph,Rule,Background Material,2003-06-13T04:00:00Z,2003,6,,,2019-06-06T15:42:36Z,,0,0,0900006480560d8f
FDA-2002-P-0171-0002,FDA,FDA-2002-P-0171,Medical Devices; Exemption From Premarket Notification; Class II  Devices; Optical Impression Systems  for Computer Assisted Design and  Manufacturing,Rule,Final Rule,2003-04-23T04:00:00Z,2003,4,,,2018-03-15T15:00:21Z,03–9869,0,0,0900006480494a96
FDA-2002-N-0016-0004,FDA,FDA-2002-N-0016,FDA - Notice of Proposed Rule-Making,Rule,NPR-Notice of Proposed Rule-Making,2003-03-19T05:00:00Z,2003,3,2003-03-19T05:00:00Z,2003-06-13T03:59:59Z,2009-02-25T14:07:45Z,,0,0,0900006480488384
FDA-2000-N-0142-0004,FDA,FDA-2000-N-0142,Notice of Correction Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use,Rule,Correction,2003-03-18T05:00:00Z,2003,3,,,2015-05-06T16:09:17Z,,0,0,09000064804d0d63
FDA-2000-N-0142-0003,FDA,FDA-2000-N-0142,Notice of Final Rule Labeling Requirements for Systemic Antibacterial Drug Products Intended for Human Use,Rule,Final Rule,2003-02-06T05:00:00Z,2003,2,2003-02-06T05:00:00Z,,2015-05-29T18:45:42Z,,0,0,09000064804d0d5c
FDA-2000-N-0011-0001,FDA,FDA-2000-N-0011,"Uniform Compliance Date for Food Labeling Regulations, January 1, 2006",Rule,NFR-Notice of Final Rule,2003-01-06T05:00:00Z,2003,1,2003-01-06T05:00:00Z,2003-03-18T04:59:59Z,2009-01-08T15:29:17Z,,0,0,09000064804ae80c